Serum fibroblast growth factor 21 levels in polycystic ovary syndrome

Gorar S., Culha C., Uc Z. A., Dellal F. D., Serter R., Aral S., ...Daha Fazla

GYNECOLOGICAL ENDOCRINOLOGY, cilt.26, sa.11, ss.819-826, 2010 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 26 Sayı: 11
  • Basım Tarihi: 2010
  • Doi Numarası: 10.3109/09513590.2010.487587
  • Dergi Adı: GYNECOLOGICAL ENDOCRINOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.819-826
  • Anahtar Kelimeler: Body mass index, insulin resistance, polycystic ovary syndrome, ACTIVATED-RECEPTOR-GAMMA, METABOLIC REGULATOR, FGF-21 LEVELS, BETA-KLOTHO, OBESITY, FGF21, FIBROBLAST-GROWTH-FACTOR-21, IDENTIFICATION, EXPRESSION, GLUCOSE
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Aim. This study was designed to measure serum fibroblast growth factor 21 (FGF21) levels in patients with polycystic ovary syndrome (PCOS) and healthy subjects.